Related Experiment Video
Updated: Apr 24, 2026

07:34
Gold Nanoparticle Modified Carbon Fiber Microelectrodes for Enhanced Neurochemical Detection
Published on: May 13, 2019
9.4K
Metal Organic Framework-Modified Carbon Fiber Microelectrodes for Enhanced Neurochemical Detection
Teflah Alshammari1,2,3, Daniel Coughlin1, Nadrah Aldaeefi1,2
1Department of Chemistry, American University, Washington, D.C. 20016.
Chemelectrochem
|April 23, 2026
Summary
Researchers enhanced dopamine detection using modified carbon fiber microelectrodes (CFMEs). The MIL-88B(Fe) material improved sensitivity and selectivity for measuring low dopamine levels in the brain.
Area of Science:
- Electrochemistry
- Neuroscience
- Materials Science
Background:
- Fast scan cyclic voltammetry (FSCV) with carbon fiber microelectrodes (CFMEs) has limitations in sensitivity and selectivity for low dopamine detection.
- Accurate measurement of dopamine is crucial for understanding brain function and neurological disorders.
Purpose of the Study:
- To enhance dopamine detection sensitivity and selectivity using MIL-88B(Fe)-modified CFMEs.
- To evaluate the performance of these modified electrodes for neurochemical detection in biological samples.
Main Methods:
- Modification of CFMEs with an iron-based metal-organic framework (MIL-88B(Fe)).
- Electrochemical characterization using FSCV with a triangle waveform.
- Testing of dopamine detection in nanomolar concentrations and biological fluids.
Main Results:
- MIL-88B(Fe)-modified CFMEs showed a ~76% increase in oxidative peak current for dopamine compared to bare CFMEs.
- Enhanced sensitivity (49 ± 3 nA/μM vs. 30 ± 2 nA/μM) and a linear response in the 10-100 nM dopamine range.
- Simultaneous detection of dopamine, tyrosine, and hydrogen peroxide with high recovery (~97%) in biological fluid.
Conclusions:
- MIL-88B(Fe) modification significantly improves dopamine detection performance of CFMEs.
- The modified electrodes offer enhanced sensitivity and selectivity for FSCV neurochemical analysis.
- This approach holds promise for more accurate dopamine level monitoring in neurological research.

